Wu et al., 2002 - Google Patents
Bax and BH3-domain-only proteins in p53-mediated apoptosisWu et al., 2002
View PDF- Document ID
- 4326491805800507031
- Author
- Wu X
- Deng Y
- Publication year
- Publication venue
- Front Biosci
External Links
Snippet
[Frontiers in Bioscience 7, d151-156, January 1, 2002] 151 BAX AND BH3-DOMAIN-ONLY
PROTEINS IN P53-MEDIATED APOPTOSIS Xiangwei W Page 1 [Frontiers in Bioscience 7,
d151-156, January 1, 2002] 151 BAX AND BH3-DOMAIN-ONLY PROTEINS IN P53-MEDIATED …
- 101710026335 TP53 0 title abstract description 79
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | Bax and BH3-domain-only proteins in p53-mediated apoptosis | |
Bassuk et al. | Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells | |
Pierrat et al. | SH3GLB, a new endophilin-related protein family featuring an SH3 domain | |
Guan et al. | Growth suppression by p18, a p16INK4/MTS1-and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. | |
US20070036775A1 (en) | Method of modulating or examining Ku70 levels in cells | |
EP1343884A2 (en) | Jfy1 protein induces rapid apoptosis | |
EP2796462A1 (en) | Anti-tumor peptide and use therefor | |
KR101161923B1 (en) | Atap peptides, nucleic acids encoding the same and associated methods of use | |
Verma et al. | Cell death regulation by B-cell lymphoma protein | |
KR20050085448A (en) | Regulatory zinc finger proteins | |
CA2520001A1 (en) | Cyclic amp response element activator proteins and uses related thereto | |
US20040053839A1 (en) | Method of protecting cells against apoptosis and assays to identify agents which modulate apoptosis | |
Vlatkovic et al. | Tissue-specific therapeutic targeting of p53 in cancer: one size does not fit all | |
US20040248775A1 (en) | Methods for screening inhibitors of apoptosis | |
Zhang | PTIP, a novel BRCT domain-containing apoptotic factor that directly promotes cytochrome c release from mitochondria to cytoplasm | |
Greider | Mechanistic examination of BCL2-induced cell cycle delay | |
Lu | Molecular cloning and functional characterization of BRCA1 splice variants in human mammary cells | |
US20040077832A1 (en) | Jfy1protein induces rapid apoptosis | |
Moll | P53 Has a Direct Pro-apoptotic Action at the Mitochondria | |
Pimmett | Vestigial-like Family Co-Factors in Drosophila Development | |
Gamble | MYCN and the p53-MDM2/MDMX-p14ARF network in neuroblastoma amd response to MDM2-p53 antagonists | |
Fleischer | Implication of Bcl-2 family members in apoptosis signalling pathways triggered by growth factor deprivation | |
AU2002253804A1 (en) | JFY1 protein induces rapid apoptosis | |
Veljkovic | Role of the mammalian transcription factor LSF (late SV40 factor) in repression of DNA polymerase alpha gene expression | |
JP2003238591A (en) | Apoptosis inducer, compound having apoptosis inducing activity, anticancer agent, drug screening method and drug screening kit |